{"count": 2, "results": [{"_id": "15532136", "pmid": 15532136, "title": "Rosuvastatin: new preparation. Opt for statins with evidence of efficacy on clinical outcome.", "journal": "Prescrire Int", "date": "2004-08-01T00:00:00Z", "meta_date_publication": "2004 Aug", "meta_volume": "13", "meta_issue": "72", "meta_pages": "132-4", "score": 50063.273, "text_hl": "...(1) @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ and @CHEMICAL_Pravastatin @CHEMICAL_MESH:D017035 @@@pravastatin@@@ are the two reference statins for @<m>DISEASE_Osteogenesis_imperfecta_type_2B</m> @DISEASE_MESH:C536043 @@@type IIA and type IIB hypercholesterolaemia@@@ because they have the best-documented protective effect against cardiovascular events. ", "citations": {"NLM": "Rosuvastatin: new preparation. Opt for statins with evidence of efficacy on clinical outcome. Prescrire Int. 2004 Aug;13(72):132-4. PMID: 15532136", "BibTeX": "@article{15532136, title={Rosuvastatin: new preparation. Opt for statins with evidence of efficacy on clinical outcome.}, journal={Prescrire Int}, volume={13}, number={72}, pages={132-4}}"}}, {"_id": "2180267", "pmid": 2180267, "title": "Hydroxymethylglutaryl coenzyme A reductase inhibitors as monotherapy in the treatment of hypercholesterolemia.", "journal": "Am J Cardiol", "authors": ["Walker JF", "Shapiro DR"], "date": "1990-03-20T00:00:00Z", "doi": "10.1016/0002-9149(90)91250-a", "meta_date_publication": "1990 Mar 20", "meta_volume": "65", "meta_issue": "12", "meta_pages": "19F-22F", "score": 50062.07, "text_hl": "A variety of double-blind studies have compared the efficacy of hydroxymethylglutaryl coenzyme A reductase inhibitors (@CHEMICAL_Lovastatin @CHEMICAL_MESH:D008148 @@@lovastatin@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@) with that of control agents (@CHEMICAL_Cholestyramine_Resin @CHEMICAL_MESH:D002792 @@@cholestyramine@@@, @CHEMICAL_Fibric_Acids @CHEMICAL_MESH:D058607 @@@fibrates@@@ and @CHEMICAL_Probucol @CHEMICAL_MESH:D011341 @@@probucol@@@) in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Osteogenesis_imperfecta_type_2B</m> @DISEASE_MESH:C536043 @@@type IIA or IIB@@@ primary @DISEASE_Hypercholesterolemia @DISEASE_MESH:D006937 @@@hypercholesterolemia@@@. ", "citations": {"NLM": "Walker JF, Shapiro DR. Hydroxymethylglutaryl coenzyme A reductase inhibitors as monotherapy in the treatment of hypercholesterolemia. Am J Cardiol. 1990 Mar 20;65(12):19F-22F. PMID: 2180267", "BibTeX": "@article{2180267, title={Hydroxymethylglutaryl coenzyme A reductase inhibitors as monotherapy in the treatment of hypercholesterolemia.}, author={Walker JF and Shapiro DR}, journal={Am J Cardiol}, volume={65}, number={12}, pages={19F-22F}}"}}]}